NSE filing, NSE: ZENITHDRUG. Summary written from the filing by ALFA Finder's alert engine.
Zenith Drugs Ltd: key numbers
- Share price
- ₹37.00
- Market cap
- ₹63.45 Cr
- Revenue (annual)
- ₹171.2 Cr
- Net profit (annual)
- ₹3.94 Cr
- P/E (TTM)
- 16.1×Sector 48.7×
- Promoter holding
- 69.98%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zenith Drugs Ltd
All →Zenith Drugs Bags ₹0.73 Cr Order from Uttar Pradesh Medical Supplies Corporation Limited
Zenith Drugs won a tender from Uttar Pradesh Medical Supplies Corporation for Betamethasone Valerate cream. The ₹0.73 Crore contract value strengthens the company's pharmaceutical supply pipeline.
- Value
- ₹0.73 Cr
- From
- Uttar Pradesh Medical Supplies Corporation Limited
Zenith Drugs Business Update
Zenith Drugs Board approved sale of a 5-hectare property in Indore for ₹13.75 Crore to ACE Engineering & Chemicals Pvt Ltd. Completion expected by November 2026.
- Value
- ₹13.75 Cr
Zenith Drugs Bags New Order from Haryana Medical Services Corporation Limited
Zenith Drugs Limited has been awarded a tender by Haryana Medical Services Corporation Limited to supply medicines for two years at Rs. 11.15 per unit.
- From
- Haryana Medical Services Corporation Limited
- Execution
- 2 years
Zenith Drugs Annual General Meeting
Zenith Drugs Limited released the voting results and Scrutinizer's Report for its 26th Annual General Meeting conducted on September 29, 2026.
Zenith Drugs Annual General Meeting
Zenith Drugs Limited has issued a notice for its 26th Annual General Meeting scheduled for September 29, 2026, to transact various ordinary and special business.
Zenith Drugs Board Meeting Outcome
Zenith Drugs Limited announced the notice for its 26th AGM and appointed a secretarial auditor and a scrutinizer for the meeting.
Other other announcement announcements
All →Aeroflex Neu Other Announcement
Aeroflex Neu filed its Reg 32 statement for the quarter ended September 30, 2026. It reports Rs 795.50 lakh utilised from Rs 6,480 lakh raised via warrants.
Shankara Buildpro Other Announcement
Shankara Buildpro reports the death of founder and Managing Director Sukumar Srinivas on October 30, 2026. He ceases to be classified as a promoter under Regulation 31A(6)(c).
Rander Corporation Other Announcement
Rander Corporation Ltd filed its quarterly BSE shareholding pattern for the quarter ended 30 September 2026. This routine Regulation 31 disclosure reports no capital or promoter transaction.
Jash Engineering Other Announcement
Jash Engineering's quarterly shareholding pattern for the period ended 30 September 2026 was filed with the exchange. It shows routine holding distribution across promoter and public categories with no transaction.
Rulka Electricals Other Announcement
Rulka Electricals filed its half-year Reg 32 statement on preferential issue proceeds. It reports no deviation, with Rs 28.31 Crore used for working capital.
Ace Alpha Tech Other Announcement
Ace Alpha Tech filed its half-yearly statement of deviation on IPO proceeds, reporting a Rs 40.11 lakh reallocation to human-resources capex approved by postal ballot. It also extended the capex utilisation timeline to FY2027-28.